Aricept (donepezil) is now approved for SEVERE Alzheimer's in Canada

  Aricept (donepezil) is now approved for SEVERE Alzheimer's in Canada.

  Aricept is the first drug approved for all stages of Alzheimer's disease...mild, moderate, and severe. About 50% of patients with Alzheimer's have moderate to severe symptoms.

     Recommend starting with Aricept 5 mg per day. Wait at least 4 to 6 weeks before considering a dose increase to 10 mg per day.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote